(Q44133337)

30 November 2017

title

Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts (English)

1 reference

30 November 2017

1 reference

Mark D Pescovitz

1

1 reference

30 November 2017

Ralph Barbeito

series ordinal

2

1 reference

30 November 2017

Simulect US01 Study Group

series ordinal

3

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

published in

Clinical Transplantation

1 reference

30 November 2017

volume

16

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

378-382

1 reference

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Neoral study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Evidence that calcineurin is rate-limiting for primary human lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

Current opinions on therapeutic drug monitoring of immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

The temporal profile of calcineurin inhibition by cyclosporine in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.02036.X

7 January 2021

10.1034/J.1399-0012.2002.02036.X

Identifiers

DOI

1 reference

30 November 2017

1 reference